Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
| No. | 60 |
|---|---|
| Citation | Circ J 84(6),p975-984(2020) |
| Institute | Yokohama City University Medical Center |
| 1st Author | S Kikuchi |
| AR | 〇 |
| PL | 〇 |
| HD | |
| Paper types | Clinical study |
| Main purpose | |
| Disease | ST-elevation myocardial infarction(STEMI) patients underwent primary percutaneous coronary intervention (PPCI) |
| Antiplatelet drug | P2Y12 receptor inhibitors |
| Anticoagulant drug | |
| Other drug | |
| Clinical specimens | |
| Animal | |
| Keyword | Infarct size; Platelet-derived thrombogenicity; Platelet function test; ST-elevation myocardial infarction |